A detailed history of Vanguard Group Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Vanguard Group Inc holds 102,277 shares of TAK stock, worth $1.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
102,277
Previous 102,277 -0.0%
Holding current value
$1.39 Million
Previous $1.32 Million 9.83%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$12.6 - $13.67 $571,989 - $620,563
45,396 Added 79.81%
102,277 $1.32 Million
Q3 2023

Nov 14, 2023

SELL
$15.03 - $16.32 $1.25 Million - $1.36 Million
-83,354 Reduced 59.44%
56,881 $879,000
Q2 2023

Aug 14, 2023

SELL
$15.57 - $17.11 $77,133 - $84,762
-4,954 Reduced 3.41%
140,235 $2.2 Million
Q1 2023

May 15, 2023

SELL
$15.28 - $16.48 $859,041 - $926,505
-56,220 Reduced 27.91%
145,189 $2.39 Million
Q4 2022

Feb 10, 2023

SELL
$12.42 - $15.62 $684,279 - $860,583
-55,095 Reduced 21.48%
201,409 $3.14 Million
Q3 2022

Nov 14, 2022

SELL
$12.8 - $28.65 $6.87 Million - $15.4 Million
-536,773 Reduced 67.67%
256,504 $3.33 Million
Q2 2022

Aug 12, 2022

SELL
$13.12 - $15.03 $7.98 Million - $9.14 Million
-608,275 Reduced 43.4%
793,277 $11.1 Million
Q1 2022

May 13, 2022

SELL
$13.54 - $15.35 $4.54 Million - $5.15 Million
-335,379 Reduced 19.31%
1,401,552 $20.1 Million
Q4 2021

Feb 14, 2022

SELL
$13.17 - $16.4 $3.38 Million - $4.21 Million
-256,677 Reduced 12.87%
1,736,931 $23.7 Million
Q3 2021

Nov 12, 2021

SELL
$16.3 - $17.26 $8.19 Million - $8.67 Million
-502,534 Reduced 20.13%
1,993,608 $32.7 Million
Q2 2021

Aug 13, 2021

BUY
$16.55 - $18.64 $41.3 Million - $46.5 Million
2,496,142 New
2,496,142 $42 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.3B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.